Amgen (AMGN) Work In Process (2013 - 2017)

Amgen (AMGN) has reported Work In Process for 5 consecutive years, with $1.6 billion the latest figure, recorded in Q2 2017.

• In Q2 2017, Work In Process changed N/A year-over-year to $1.6 billion; the TTM figure through Jun 2017 stood at $1.6 billion (changed N/A YoY), while the FY2016 annual figure was $1.6 billion, up 5.17% from the prior year.
• Work In Process came in at $1.6 billion for Q2 2017 at Amgen, up from $1.5 billion in the prior quarter.
• The five-year high for Work In Process was $2.1 billion in Q4 2013, with the low at $1.3 billion in Q2 2015.
• Average Work In Process over 5 years is $1.6 billion, with a median of $1.6 billion recorded in 2014.
• Across the five-year window, Work In Process retreated 28.1% in 2015 and grew 5.17% in 2016, its largest moves.
• Year by year, Work In Process stood at $2.1 billion in 2013, then dropped by 24.85% to $1.6 billion in 2014, then declined by 1.42% to $1.5 billion in 2015, then increased by 5.17% to $1.6 billion in 2016, then gained by 0.62% to $1.6 billion in 2017.
• According to Business Quant data, Work In Process over the past three periods registered $1.6 billion, $1.5 billion, and $1.6 billion for Q2 2017, Q1 2017, and Q4 2016 respectively.